Get in touch
Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.
PanTracer™ LBx is now available! - Order now
This test uses RT-PCR and sequencing to detect BCR-ABL1 fusion transcript mutations associated with resistance to Gleevec (imatinib) and other tyrosine kinase inhibitors.
Includes analysis of common mutations like T315I, Y253H, E255K/V, F359V/C/I, F317L/V/I/C, T315A, and V299L.
Bone Marrow Aspirate: 2 mL in EDTA tube.
Peripheral Blood: 5 mL in EDTA tube.
Note: Test is RNA-based. Please select Extract & Hold - RNA If specimen hold service is desired.
81170
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.
Last Updated: August 05, 2025